Each institution was requested to check the number of transplants they reported and to confirm or to correct the figures. As of 15 March 2004, replies had been received from 135 centres reporting a median of 48 transplants per centre over the study period, total 17 891 (58% of the total number). Among them, 55 confirmed their original figures, while 80 corrected the numbers. The overall number of autologous and allogeneic SCTs performed and not reported were 461 and 692, respectively. Most of the teams that corrected their figures stated that their data managers could provide missing data to the EBMT; 260 other teams, each reporting a median of 15 transplants during the study period, total 12 866 (42% of the total number) chose not to reply. Haematopoietic stem cell transplantation (SCT) has become a well-established therapy for many severe congenital or acquired disorders of the haematopoietic system, and for chemosensitive, radiosensitive, or immunosensitive malignancies in children and adolescents. [1] [2] [3] [4] [5] The information deriving from large series of consecutive patients treated in several centres offers an approach for addressing issues in this field and provides a resource for evaluating the changes that have occurred over the last years. With this aim in mind, all EBMT (European Bone Marrow Transplantation Group) members and affiliated nonmembers have reported data on transplanted patients to the EBMT Registry since 1970. A recent report on the paediatric transplantation activity registered between 1970 and 2002 in the EBMT database shows a decrease in the number of SCT registrations in 2001 and in 2002. Moreover, data concerning distribution in the various countries show discrepancies between National Registries and the EBMT Registry. 6 In order to validate this observation, the Paediatric Diseases Working Party (PDsWP) secretariat distributed a questionnaire on SCT activity to institutions participating in the EBMT Registry. The aim of this paper is to report the preliminary results of this survey and to provide the full picture regarding all children given SCTs between 1970 and 2002.
Design and methods
Data collection is based on the EBMT Registry. In March 2003, the PDsWP secretariat downloaded the number of SCTs carried out on patients below 18 years of age that had been reported to the EBMT Registry between 1970 and December 2002. A questionnaire was then distributed to all the EBMT centres involved in this programme. Each institution was requested to check the number of autologous and allogeneic transplants performed within December 2000, as well as in 2001, and in 2002, respectively, and to confirm or to correct the figures immediately. They were asked to supply the number of transplants that were actually performed and to provide missing data to the EBMT Registry directly or through the National Registry.
Each institution was requested to state: if its data manager was able to provide missing data to the EBMT either directly or through the National Registry; if he/she was not able to provide missing data but would appreciate receiving assistance from the EBMT office; and if missing data had already been sent to the EBMT office directly or through the National Registry.
Institutions were classified as: category 1, when they registered children alone; category 2, when more than 25% of registered patients were children; and category 3, when less than 25% of registered patients were children. In order to verify the impact of this survey, the number of SCTs carried out on patients below 18 years of age reported between 1970 and December 2002 were again downloaded in March 2004. Among the 420 centres, 16 were not reported in the EBMT mailing list and did not receive the questionnaire, despite several efforts to reach them; 319 teams were contacted directly, while 85 institutions from Austria, Czech Republic, Italy, Netherlands, Switzerland, and the United Kingdom received the questionnaires through National Registries. As of 15 March, 2004, 135 centres (60 category 1, 9 category 2, and 66 category 3, reporting 1-1152 transplants in the study period, median 48, total 17 891) had replied to the questionnaire. Among them, 55 confirmed their original figures, while 80 (48 category 1, 5 category 2, and 27 category 3) corrected the numbers. A summary of the transplants reported to the EBMT database and of the transplants that were actually performed by the institutions that answered the questionnaire is reported in Tables 1 and 2 . A detailed activity report can be found in the Appendix, in alphabetical order according to country, city, and EBMT centre code. The overall number of autologous and allogeneic SCTs performed and not reported were 498 and 692, respectively. Among the 80 teams that corrected their figures, 65 (43 category 1, 4 category 2, and 18 category 3) stated that their data managers were able to provide missing data to the EBMT either directly or through the national registry; one centre stated that its data manager was not able to provide missing data but would appreciate receiving assistance from the EBMT office; eight stated that missing data had already been sent to the EBMT office directly or through the national registry, the remaining 6 did not answer this question.
Results
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Discussion
These data reflect the current practice in reporting SCT in childhood in Europe and point to the changes in the number of transplants reported over the last few years. Since 1970, all EBMT members and affiliated nonmembers have collected data concerning transplanted patients. Participating teams are required to register Minimal Essential Data (MED-A) of all consecutive patients. Disease-oriented (MED-B) forms are filled-in by several teams. The EBMT data managers' job initially involved keeping the data on up to 800 patients provided by 20 centres in an Excel spreadsheet. Today, it extends to 20 000 registrations provided each year by 600 centres through an internet application, with all the complexities that this entails. Since 1990, the EBMT-JACIE (Joint Accreditation Committee International Society for Cell Therapy and EBMT Accreditation Office) initiated an EBMT activity survey, as a rapid tool for quality control and trend assessment. 7 This activity survey collects numbers of SCT from each participating institution annually, by indication, donor type and stem-cell source, on a single-page questionnaire. During last few years, 465 of 473 member teams returned the survey sheet, corresponding to a 92% return rate.
8 Unfortunately, it does not provide any information on the age of patients. Since 1995, the PDsWP was set up within the EBMT group 9 because it became clear that the strategies concerning both SCT and supportive therapy are different in children, adolescents, and adults. Moreover, in paediatrics, one deals with a growing and developing organism with a hopefully long life expectancy. Late effects such as growth retardation, hormonal deregulations, and sterility have a completely different impact from what is observed in adults. As a consequence, it became clear that some characteristics concerning children might be elucidated only through controlled trials restricted to this age group.
Our data show that the decreased activity reported in the 2003 report 6 did not correspond to a decrease in the number of transplants that were actually performed. This decrease was probably related to the fact that some teams which had previously reported transplants to the EBMT Registry decided to no longer report their data, or encountered problems with the introduction of ProMISE. This hypothesis is confirmed by reports from the activity survey of the Accreditation Committee of the EBMT. 8 This first PDsWP survey, reaching more than 50% of activity in the field, provides an objective analysis of current practice in reporting data to the EBMT Registry. It illustrates problems that were encountered by several teams, but it shows the willingness to cooperate with most major paediatric institutions: 135 teams, each reporting a median of 48 SCTs had replied to the questionnaire. Among them, 54 confirmed their original figures, while 461 autologous and 692 allogeneic SCTs that had previously not been reported to the EBMT database were registered with the PDsWP secretariat. Most of these teams stated that their data managers were able to provide missing data to the EBMT either directly or through the national registry.
The report prepared in March 2004, following the PDsWP survey, showed an increase in the number of transplants that were performed on patients below 18 years of age between 1973 and 2002, and that were reported to the EBMT Registry (328 autologous and 628 allogeneic).
This survey contributes to validate the data on paediatric transplants that have been reported to the EBMT registry, and confirms that they may represent a rational basis for health-care planning and patient counselling. That is why reporting data to the EBMT Registry should be considered an essential criterion for the yearly accreditation of EBMT full members. Some questions such as how data quality could be improved, who should be in charge of data validation, and updating can be answered only through a deep cooperation among Natonal Registries, EBMT Registry and Paediatric Diseases Working Party. 
